BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34435631)

  • 1. Inhaled Corticosteroids Increase Risk of Nontuberculous Mycobacterial Lung Disease: A Nested Case-Control Study and Meta-analysis.
    Shu CC; Wei YF; Chen KH; Chuang S; Wang YH; Wang CY; Wang HC
    J Infect Dis; 2022 Feb; 225(4):627-636. PubMed ID: 34435631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of mycobacterial infections associated with inhaled corticosteroid use.
    Brode SK; Campitelli MA; Kwong JC; Lu H; Marchand-Austin A; Gershon AS; Jamieson FB; Marras TK
    Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28931659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled Corticosteroids and Mycobacterial Infection in Patients with Chronic Airway Diseases: A Systematic Review and Meta-Analysis.
    You Y; Ni Y; Shi G
    Respiration; 2022; 101(10):970-980. PubMed ID: 35998604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long-term inhaled corticosteroid therapy.
    Hojo M; Iikura M; Hirano S; Sugiyama H; Kobayashi N; Kudo K
    Respirology; 2012 Jan; 17(1):185-90. PubMed ID: 21995339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical analysis of chronic obstructive pulmonary disease patients complicated with nontuberculous mycobacterial pulmonary disease].
    Sun YX; Shao C; Li S; Xu K; Huang H; Xu ZJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Nov; 42(11):826-831. PubMed ID: 31694092
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhaled Corticosteroids and the Risk of Nontuberculous Mycobacterial Pulmonary Disease in Chronic Obstructive Pulmonary Disease: Findings from a Nationwide Population-Based Study.
    Yu I; Hong SH; Chang MS; Lee SJ; Yong SJ; Lee WY; Kim SH; Lee JH
    J Pers Med; 2023 Jun; 13(7):. PubMed ID: 37511700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Inhaled Corticosteroid Use and Pulmonary Nontuberculous Mycobacterial Infection.
    Liu VX; Winthrop KL; Lu Y; Sharifi H; Nasiri HU; Ruoss SJ
    Ann Am Thorac Soc; 2018 Oct; 15(10):1169-1176. PubMed ID: 30213194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for nontuberculous mycobacterial pulmonary disease (NTM-PD) in Croatia.
    Glodić G; Samaržija M; Sabol I; Bulat Kardum L; Carević Vladić V; Džubur F; Jakopović M; Kuhtić I; Marušić A; Mihelčić D; Popović Grle S; Strelec D; Šklebar T; Šola AM; Žmak L; van Ingen J; Janković Makek M
    Wien Klin Wochenschr; 2021 Nov; 133(21-22):1195-1200. PubMed ID: 34402990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationships between COPD and nontuberculous mycobacteria pulmonary infections].
    Balavoine C; Andréjak C; Marchand-Adam S; Blanc FX
    Rev Mal Respir; 2017 Dec; 34(10):1091-1097. PubMed ID: 29150178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis.
    Andréjak C; Nielsen R; Thomsen VØ; Duhaut P; Sørensen HT; Thomsen RW
    Thorax; 2013 Mar; 68(3):256-62. PubMed ID: 22781123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance and diagnosis of nontuberculous mycobacterial pulmonary disease in populations at risk.
    Feng JY; Chen WC; Chen YY; Su WJ
    J Formos Med Assoc; 2020 Jun; 119 Suppl 1():S23-S31. PubMed ID: 32482607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing nontuberculous mycobacterial lung disease and Mycobacterium tuberculosis lung disease on X-ray images using deep transfer learning.
    Park M; Lee Y; Kim S; Kim YJ; Kim SY; Kim Y; Kim HM
    BMC Infect Dis; 2023 Jan; 23(1):32. PubMed ID: 36658559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
    Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
    [No Abstract]   [Full Text] [Related]  

  • 14. Real-world treatment patterns in patients with nontuberculous mycobacterial lung disease in the Netherlands based on medication dispensing data.
    Hoefsloot W; Dacheva E; van der Laan R; Krol M; van Ingen J; Obradovic M; Liu X
    BMC Pulm Med; 2023 Jun; 23(1):218. PubMed ID: 37340431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination.
    Lee MR; Yang CY; Shu CC; Lin CK; Wen YF; Lee SW; Ko JC; Wang JY; Lee LN; Yu CJ
    Clin Microbiol Infect; 2015 Mar; 21(3):250.e1-7. PubMed ID: 25658545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing Epidemiology of Nontuberculous Mycobacterial Lung Diseases in a Tertiary Referral Hospital in Korea between 2001 and 2015.
    Ko RE; Moon SM; Ahn S; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Koh WJ
    J Korean Med Sci; 2018 Feb; 33(8):e65. PubMed ID: 29441757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttreatment Lymphopenia Is Associated With an Increased Risk of Redeveloping Nontuberculous Lung Disease in Patients With Mycobacterium avium Complex Lung Disease.
    Furuuchi K; Fujiwara K; Uesgi F; Shimoda M; Seto S; Tanaka Y; Yoshiyama T; Yoshimori K; Kurashima A; Ohta K; Morimoto K
    Clin Infect Dis; 2021 Jul; 73(1):e152-e157. PubMed ID: 32507892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eliciting Patient Insights on the Burden of Nontuberculous Mycobacterial Lung Disease (NTM-LD) and Healthcare Gaps in Germany Through Qualitative Semi-structured Interviews.
    Hoenig C; van der Laan R; Reimann A; Hoffmann M; Tyler S; Wiesmann C; Obradovic M
    Adv Ther; 2023 Jun; 40(6):2915-2926. PubMed ID: 37150804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multidisciplinary approach to the management of nontuberculous mycobacterial lung disease: a clinical perspective.
    Ali J
    Expert Rev Respir Med; 2021 May; 15(5):663-673. PubMed ID: 33593217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease Progression in Patients With Nontuberculous Mycobacterial Lung Disease of Nodular Bronchiectatic (NB) Pattern: The Roles of Cavitary NB and Soluble Programmed Death Protein-1.
    Pan SW; Su WJ; Chan YJ; Ho ML; Feng JY; Shu CC; Wang JY; Wang HC; Yu CJ; Chen YM
    Clin Infect Dis; 2022 Aug; 75(2):239-247. PubMed ID: 34726741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.